COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,572 Articles (22,415 medRxiv, 8,157 bioRxiv)

Most recent first Previous |  Page 2651: Articles 26501-26510  | Next

Diligent medical activities of a publicly designated medical institution for infectious diseases pave the way for overcoming COVID-19: A positive message to people working at the cutting edge
Nagano, T., Arii, J., Nishimura, M., Yoshida, N., Iida, K., Nishimura, Y., Mori, Y.
10.1101/2020.05.19.20107490 — Posted: 2020-05-25 Discussion: Onsite
Management of mild COVID-19: Policy implications of initial experience in India
Kumar, R., bhattacharya, b., Meena, V. P., Aggarwal, A., Tripathi, M., Soneja, M., Mittal, A., Singh, K., Gupta, N., Garg, R. K., Ratre, B., Kumar, B., Bhopale, S., Tiwari, P., Verma, A., Bhatnagar, S., Mohan, A., Wig, N., Guleria, R.
10.1101/2020.05.20.20107664 — Posted: 2020-05-25
Influence of countries adopted policies for COVID-19 reduction under the view of the airborne transmission framework
Telles, C. R.
10.1101/2020.05.20.20107763 — Posted: 2020-05-25
Age- and sex-specific total mortality impacts of the early weeks of the Covid-19 pandemic in England and Wales: Application of a Bayesian model ensemble to mortality statistics
Kontis, V., Bennett, J. E., Parks, R. M., Rashid, T., Pearson-Stuttard, J., Asaria, P., Guillot, M., Blangiardo, M., Ezzati, M.
10.1101/2020.05.20.20107680 — Posted: 2020-05-25
Coronavirus (COVID-19) infection in children at a specialist centre: outcome and implications of underlying high-risk comorbidities in a paediatric population
Issitt, R., Booth, J., Bryant, W., Spiridou, A., Taylor, A., DuPre, P., Ramnarayan, P., Hartley, J., Cortino Borja, M., Moshal, K., Dunn, H., Hemingway, H., Sebire, N.
10.1101/2020.05.20.20107904 — Posted: 2020-05-25
Quantifying Effects, Forecasting Releases, and Herd Immunity of the Covid-19 Epidemic in S. Paulo, Brazil
Celaschi, S.
10.1101/2020.05.20.20107912 — Posted: 2020-05-25
Risk factors affecting COVID-19 case fatality rate: A quantitative analysis of top 50 affected countries
Goh, H. P., Mahari, W. I., Ahad, N. I., Chaw, L., Kifli, N., Goh, B. H., Yeoh, S. F., Ming, L. C.
10.1101/2020.05.20.20108449 — Posted: 2020-05-25 Discussion: Onsite
Spread of COVID-19: Investigation of universal features in real data
Das, S. K.
10.1101/2020.05.20.20107797 — Posted: 2020-05-25
Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area
Kraehling, V., Kern, M., Halwe, S., Mueller, H., Rohde, C., Savini, M., Schmidt, M., Wilhelm, J., Becker, S., Ciesek, S., Gottschalk, R.
10.1101/2020.05.20.20107730 — Posted: 2020-05-25
Prevalence of SARS-CoV-2 infection among asymptomatic healthcare workers in greater Houston: a cross-sectional analysis of surveillance data from a large healthcare system
Vahidy, F., Sostman, H. D., Bernard, D., Boom, M. L., Drews, A. L., Christensen, P. A., Finkelstein, J., Kash, B. A., Phillips, R. A., Schwartz, R. L.
10.1101/2020.05.21.20107581 — Posted: 2020-05-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).